{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:28Z","timestamp":1787020348774,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T00:00:00Z","timestamp":1759190400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-24093-1","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:35:49Z","timestamp":1759232149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and prioritization of the French surveillance program of health effects in the context of exposure to endocrine disruptors using a Delphi study"],"prefix":"10.1186","volume":"25","author":[{"given":"Alexia","family":"Peyronnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e9lina","family":"Le Barbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Naud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Menard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Caudeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,30]]},"reference":[{"key":"24093_CR1","volume-title":"Global assessment on the state of the science of endocrine disruptors","author":"International Programme on Chemical S","year":"2002","unstructured":"International Programme on Chemical S. Global assessment on the state of the science of endocrine disruptors. Geneva: World Health Organization; 2002."},{"key":"24093_CR2","unstructured":"United Nations Environment Programme, World Health Organization. State of the Science of Endocrine Disrupting Chemicals. 2012."},{"issue":"4","key":"24093_CR3","doi-asserted-by":"publisher","first-page":"A104","DOI":"10.1289\/ehp.1205448","volume":"121","author":"A Bergman","year":"2013","unstructured":"Bergman A, Heindel JJ, Kasten T, Kidd KA, Jobling S, Neira M, et al. The impact of endocrine disruption: a consensus statement on the state of the science. Environ Health Perspect. 2013;121(4):A104-6.","journal-title":"Environ Health Perspect"},{"issue":"12","key":"24093_CR4","first-page":"e4834","volume":"106","author":"EV Br\u00e4uner","year":"2021","unstructured":"Br\u00e4uner EV, Lim YH, Koch T, Uldbjerg CS, Gregersen LS, Pedersen MK, et al. Endocrine disrupting chemicals and risk of testicular cancer: A systematic review and Meta-analysis. J Clin Endocrinol Metab. 2021;106(12):e4834\u201360.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"24093_CR5","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1093\/humupd\/dmq061","volume":"17","author":"D Caserta","year":"2011","unstructured":"Caserta D, Mantovani A, Marci R, Fazi A, Ciardo F, La Rocca C, et al. Environment and women\u2019s reproductive health. Hum Reprod Update. 2011;17(3):418\u201333.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"24093_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2478\/bimo-2014-0010","volume":"1","author":"C Fillol","year":"2014","unstructured":"Fillol C, Garnier R, Mullot JU, Boudet C, Momas I, Salmi LR, et al. Prioritization of the biomarkers to be analyzed in the French biomonitoring program. Biomonitoring. 2014;1(1):95\u2013104.","journal-title":"Biomonitoring"},{"key":"24093_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.envint.2020.106340","volume":"147","author":"C Fillol","year":"2021","unstructured":"Fillol C, Oleko A, Saoudi A, Zeghnoun A, Balicco A, Gane J, et al. Exposure of the French population to bisphenols, phthalates, parabens, glycol ethers, brominated flame retardants, and perfluorinated compounds in 2014\u20132016: results from the Esteban study. Environ Int. 2021;147:1\u201313.","journal-title":"Environ Int"},{"key":"24093_CR8","unstructured":"Sant\u00e9 publique France. Sant\u00e9 reproductive et perturbateurs endocriniens. Bull Epid\u00e9miologique Hebdomadaire. 2018:22\u20133."},{"issue":"1","key":"24093_CR9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/eurpub\/ckv153","volume":"26","author":"J Le Moal","year":"2016","unstructured":"Le Moal J, Sharpe RM, J\u03d5rgensen N, Levine H, Jurewicz J, Mendiola J, et al. Toward a multi-country monitoring system of reproductive health in the context of endocrine disrupting chemical exposure. Eur J Pub Health. 2016;26(1):76\u201383.","journal-title":"Eur J Pub Health"},{"issue":"5","key":"24093_CR10","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1093\/humrep\/deaa378","volume":"36","author":"J Le Moal","year":"2021","unstructured":"Le Moal J, Goria S, Guillet A, Rigou A, Chesneau J. Time and spatial trends of operated cryptorchidism in France and environmental hypotheses: a nationwide study from 2002 to 2014. Hum Reprod. 2021;36(5):1383\u201394.","journal-title":"Hum Reprod"},{"key":"24093_CR11","volume-title":"\u00c9pid\u00e9miologie du fibrome ut\u00e9rin Pris En charge m\u00e9dicalement En France de 2013 \u00e0 2017","author":"A Peyronnet","year":"2022","unstructured":"Peyronnet A, Goria S, Chesneau J, Le Moal J. \u00c9pid\u00e9miologie du fibrome ut\u00e9rin Pris En charge m\u00e9dicalement En France de 2013 \u00e0 2017. Saint-Maurice: Sant\u00e9 publique France; 2022."},{"key":"24093_CR12","unstructured":"Kortenkamp A, Martin OV, Faust M, Evans R, McKinlay R, Orton F, et al. editors. State of the art assessment of endocrine disruptors: Final Report. 2011."},{"key":"24093_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.envres.2015.06.014","volume":"142","author":"M Ejaredar","year":"2015","unstructured":"Ejaredar M, Nyanza EC, Ten Eycke K, Dewey D. Phthalate exposure and childrens neurodevelopment: A systematic review. Environ Res. 2015;142:51\u201360.","journal-title":"Environ Res"},{"key":"24093_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph18041464","author":"S Amir","year":"2021","unstructured":"Amir S, Shah STA, Mamoulakis C, Docea AO, Kalantzi OI, Zachariou A, et al. Endocrine disruptors acting on estrogen and androgen pathways cause reproductive disorders through multiple mechanisms: a review. Int J Environ Res Public Health. 2021. https:\/\/doi.org\/10.3390\/ijerph18041464.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"24093_CR15","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1080\/10408444.2021.2009438","volume":"51","author":"O Sabuz Vidal","year":"2021","unstructured":"Sabuz Vidal O, Deepika D, Schuhmacher M, Kumar V. EDC-induced mechanisms of immunotoxicity: a systematic review. Crit Rev Toxicol. 2021;51(7):634\u201352.","journal-title":"Crit Rev Toxicol"},{"issue":"1","key":"24093_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/humupd\/dmw036","volume":"23","author":"JP Bonde","year":"2016","unstructured":"Bonde JP, Flachs EM, Rimborg S, Glazer CH, Giwercman A, Ramlau-Hansen CH, et al. The epidemiologic evidence linking prenatal and postnatal exposure to endocrine disrupting chemicals with male reproductive disorders: a systematic review and meta-analysis. Hum Reprod Update. 2016;23(1):104\u201325.","journal-title":"Hum Reprod Update"},{"issue":"1","key":"24093_CR17","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41574-019-0273-8","volume":"16","author":"MA La Merrill","year":"2020","unstructured":"La Merrill MA, Vandenberg LN, Smith MT, Goodson W, Browne P, Patisaul HB, et al. Consensus on the key characteristics of endocrine-disrupting chemicals as a basis for hazard identification. Nat Rev Endocrinol. 2020;16(1):45\u201357.","journal-title":"Nat Rev Endocrinol"},{"key":"24093_CR18","volume-title":"State of the Science of Endocrine Disrupting Chemicals \u2013\u20092012","author":"\u00c5 Bergman","year":"2013","unstructured":"Bergman \u00c5, Heindel J, Jobling S, Kidd K, Zoeller R. State of the Science of Endocrine Disrupting Chemicals \u2013\u20092012. World Health Organization \/ United Nations Environment Programme; 2013."},{"issue":"5","key":"24093_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2021.101562","volume":"35","author":"J K\u00f6hrle","year":"2021","unstructured":"K\u00f6hrle J, Fr\u00e4drich C. Thyroid hormone system disrupting chemicals. Best Pract Res Clin Endocrinol Metab. 2021;35(5): 101562.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"24093_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.eprac.2023.11.002","volume":"30","author":"EN Pearce","year":"2024","unstructured":"Pearce EN. Endocrine disruptors and thyroid health. Endocr Pract. 2024;30(2):172\u20136.","journal-title":"Endocr Pract"},{"key":"24093_CR21","volume-title":"\u00c9laboration d\u2019une liste de substances chimiques d\u2019int\u00e9r\u00eat en raison de leur activit\u00e9 endocrine potentielle. M\u00e9thode d\u2019identification et strat\u00e9gie de priorisation pour l\u2019\u00e9valuation","author":"Anses","year":"2021","unstructured":"Anses. \u00c9laboration d\u2019une liste de substances chimiques d\u2019int\u00e9r\u00eat en raison de leur activit\u00e9 endocrine potentielle. M\u00e9thode d\u2019identification et strat\u00e9gie de priorisation pour l\u2019\u00e9valuation. Maisons-Alfort; 2021."},{"issue":"Suppl 1","key":"24093_CR22","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.2105\/AJPH.2004.044727","volume":"95","author":"S Krimsky","year":"2005","unstructured":"Krimsky S. The weight of scientific evidence in policy and law. Am J Public Health. 2005;95(Suppl 1):S129-36.","journal-title":"Am J Public Health"},{"key":"24093_CR23","volume-title":"\u00c9valuation du Poids des preuves \u00e0 l\u2019anses: revue critique de La litt\u00e9rature et recommandations \u00e0 l\u2019\u00e9tape d\u2019identification des dangers","author":"D Makowski","year":"2016","unstructured":"Makowski D, Albert I, Bonvallot N, Boudia S, Brochot C, Bruyere O. \u00c9valuation du Poids des preuves \u00e0 l\u2019anses: revue critique de La litt\u00e9rature et recommandations \u00e0 l\u2019\u00e9tape d\u2019identification des dangers. Maisons-Alfort: Anses; 2016."},{"issue":"4","key":"24093_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/andr.12178","volume":"4","author":"L Trasande","year":"2016","unstructured":"Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, et al. Burden of disease and costs of exposure to endocrine disrupting chemicals in the European union: an updated analysis. Andrology. 2016;4(4):565\u201372.","journal-title":"Andrology"},{"issue":"4","key":"24093_CR25","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1210\/jc.2014-4324","volume":"100","author":"L Trasande","year":"2015","unstructured":"Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, et al. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100(4):1245\u201355.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"24093_CR26","doi-asserted-by":"publisher","first-page":"i","DOI":"10.3310\/hta2030","volume":"2","author":"MK Murphy","year":"1998","unstructured":"Murphy MK, Black NA, Lamping DL, McKee CM, Sanderson CF, Askham J, et al. Consensus development methods, and their use in clinical guideline development. Health Technol Assess. 1998;2(3):i\u2013iv.","journal-title":"Health Technol Assess"},{"key":"24093_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.3389\/fpubh.2020.00457","volume":"8","author":"M Niederberger","year":"2020","unstructured":"Niederberger M, Spranger J. Delphi technique in health sciences: a map. Front Public Health. 2020;8:457.","journal-title":"Front Public Health"},{"key":"24093_CR28","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17228597","author":"M Salgado","year":"2020","unstructured":"Salgado M, Vieira ACL, Torres A, Oliveira MD. Selecting indicators to monitor and assess environmental health in a Portuguese urban setting: a participatory approach. Int J Environ Res Public Health. 2020. https:\/\/doi.org\/10.3390\/ijerph17228597.","journal-title":"Int J Environ Res Public Health"},{"issue":"8","key":"24093_CR29","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S2213-8587(20)30129-7","volume":"8","author":"LG Kahn","year":"2020","unstructured":"Kahn LG, Philippat C, Nakayama SF, Slama R, Trasande L. Endocrine-disrupting chemicals: implications for human health. Lancet Diabetes Endocrinol. 2020;8(8):703\u201318.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"24093_CR30","unstructured":"Com-Ruelle L, Lecomte T, Le Fur P, Mizrahi A, Sermet C. Un indicateur de gravit\u00e9 des maladies. Enqu\u00eate sur la sant\u00e9 et les soins m\u00e9dicaux France 1991-92 CREDES. 1997."},{"issue":"4","key":"24093_CR31","first-page":"354","volume":"17","author":"WHO Quality of Life Assessment Group","year":"1996","unstructured":"WHO Quality of Life Assessment Group. What quality of life? The WHOQOL group. World health organization quality of life assessment. World Health Forum. 1996;17(4):354\u20136.","journal-title":"World Health Forum"},{"issue":"4","key":"24093_CR32","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","volume":"32","author":"F Hasson","year":"2000","unstructured":"Hasson F, Keeney S, McKenna H. Research guidelines for the Delphi survey technique. J Adv Nurs. 2000;32(4):1008\u201315.","journal-title":"J Adv Nurs"},{"issue":"6","key":"24093_CR33","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1210\/er.2015-1093","volume":"36","author":"AC Gore","year":"2015","unstructured":"Gore AC, Chappell VA, Fenton SE, Flaws JA, Nadal A, Prins GS, et al. Executive summary to EDC-2: the endocrine society\u2019s second scientific statement on endocrine-disrupting chemicals. Endocr Rev. 2015;36(6):593\u2013602.","journal-title":"Endocr Rev"},{"key":"24093_CR34","doi-asserted-by":"publisher","first-page":"101179","DOI":"10.1016\/j.mex.2020.101179","volume":"8","author":"U Schmalz","year":"2021","unstructured":"Schmalz U, Spinler S, Ringbeck J. Lessons learned from a two-round Delphi-based scenario study. MethodsX. 2021;8:101179.","journal-title":"MethodsX"},{"issue":"4","key":"24093_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1177\/030802269806100403","volume":"61","author":"T Sumsion","year":"1998","unstructured":"Sumsion T. The Delphi technique: an adaptive research tool. Br J Occup Therapy. 1998;61(4):153\u20136.","journal-title":"Br J Occup Therapy"},{"issue":"3","key":"24093_CR36","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1046\/j.1365-2524.1999.00176.x","volume":"7","author":"B Green","year":"1999","unstructured":"Green B, Jones M, Hughes D, Williams A. Applying the Delphi technique in a study of GPS\u2019 information requirements. Health Soc Care Community. 1999;7(3):198\u2013205.","journal-title":"Health Soc Care Community"},{"issue":"4","key":"24093_CR37","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"IR Diamond","year":"2014","unstructured":"Diamond IR, Grant RC, Feldman BM, Pencharz PB, Ling SC, Moore AM, et al. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67(4):401\u20139.","journal-title":"J Clin Epidemiol"},{"key":"24093_CR38","volume-title":"\u00c9pid\u00e9miologie de l\u2019endom\u00e9triose prise En charge \u00e0 l\u2019h\u00f4pital En france: \u00e9tude de 2011 \u00e0 2017","author":"J Le Moal","year":"2022","unstructured":"Le Moal J, Goria S, Chesneau J, Fauconnier A, Kvaskoff M, De Crouy-Chanel P, et al. \u00c9pid\u00e9miologie de l\u2019endom\u00e9triose prise En charge \u00e0 l\u2019h\u00f4pital En france: \u00e9tude de 2011 \u00e0 2017. Saint-Maurice: Sant\u00e9 publique France; 2022."},{"issue":"1","key":"24093_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1530\/EJE-17-0379","volume":"178","author":"J Le Moal","year":"2018","unstructured":"Le Moal J, Rigou A, Le Tertre A, De Crouy-Channel P, L\u00e9ger J, Carel JC. Marked geographic patterns in the incidence of idiopathic central precocious puberty: a nationwide study in France. Eur J Endocrinol. 2018;178(1):33\u201341.","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"24093_CR40","doi-asserted-by":"publisher","first-page":"e20476","DOI":"10.1371\/journal.pone.0020476","volume":"6","author":"R Boulkedid","year":"2011","unstructured":"Boulkedid R, Abdoul H, Loustau M, Sibony O, Alberti C. Using and reporting the Delphi method for selecting healthcare quality indicators: a systematic review. PLoS One. 2011;6(6):e20476.","journal-title":"PLoS One"},{"key":"24093_CR41","unstructured":"Sackman H, editor. Delphi critique: expert opinion, forecasting, and group process. 1975."},{"issue":"1","key":"24093_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/160940691401300101","volume":"13","author":"AJ Fletcher","year":"2014","unstructured":"Fletcher AJ, Marchildon GP. Using the Delphi method for qualitative, participatory action research in health leadership. Int J Qual Methods. 2014;13(1):1\u201318.","journal-title":"Int J Qual Methods"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24093-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-24093-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-24093-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T11:36:03Z","timestamp":1759232163000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-24093-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["24093"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-24093-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"assertion":[{"value":"9 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study whose results are submitted for publication is a survey of stakeholders (health professionals, scientific experts, patient associations, etc.) to help us define our new epidemiological surveillance strategy for endocrine disruptors. It is therefore an opinion survey. No health data relating to respondents or their patients or members was collected. In view of the study\u2019s purpose and the way in which it was implemented, this study is not research involving the human person within the meaning of French legislation (article L. 1121-1 of the Public Health Code), nor within the meaning of the WMA\u2019s Declaration of Helsinki, and did not require the prior opinion of an ethics committee. However, informed consent was obtained after being informed of the conditions under which their data would be processed.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3220"}}